Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery

Major Inclusion Criteria: * Scheduled for non-emergent, hepatic surgery * Presence of an appropriate target bleeding site (TBS) as defined by the protocol Major Exclusion Criteria: * Subject will be undergoing a laparoscopic hepatic procedure where the Hemostatic Patch will be delivered and applied through a trocar * In subjects with documented history of cirrhosis, subject has uncorrected platelet count \<60,000 per mm³ as determined by laboratory tests performed immediately prior to surgery * Subject has severe coagulopathy defined as INR \> 2.0 * Subject has Total Bilirubin \>2.5mg/dL * Subject has an active local infection at the Target Bleeding Site * Study procedure involves a liver transplant recipient